$Jnj “Anti-CD38 mAbs have been also successfully tested in other plasma cell dyscrasias (such as AL amyloidosis)&amp;they are examined in other hematological malignancies (such as CLL, ALL, AML, etc.) and even in solid oncology as well as in autoimmune disorders.” @JNJCares $atnm https://t.co/2BRtJs54Sr